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Abstract
Background: The increasing importance of pulmonary function testing in diagnosing and managing lung diseases
and assessing improvement has necessitated the need for locally derived reference equations from a sample of the
general Nigerian population.
Methods: It was a cross sectional study in which we used linear regression models to obtain equations for reference
values and lower limits of normal for spirometric indices in adult Nigerians from a sample of the general population
aged 18–65 years (males) and 18–63 years (females).
Results: Seven hundred and twenty participants made up of 358 males and 362 females who satisfactorily completed
the spirometric measurements using the ATS/ERS reproducibility and acceptability criteria were included in the analysis.
The most important predictive variables were height and age. The values of the spirometic indices increase with
increasing stature but decrease with increasing age in both sexes. The sex difference in all the indices is also apparent
as all the indices, except FEV1/FVC, are higher in men than in women.
Our values are higher than values obtained from previous studies in Nigeria (except FEV1/FVC) but the differences were
not statistically significant. This suggests that although the values are increasing, the increase is yet to be significantly
different from values obtained using the past equations. The implication of this is that there is need for periodic study
to derive new equations so as to recognise when there is significant difference.
There was no significant difference between values from our equations and those obtained from study among
Ethiopians. Compared to report from Iran, our FVC and FEV1values (in males and females) as well as PEFR (in females)
are significantly lower. Our values are also lower than values from Poland. We also observed disparities between our
values and those of Afro Americans from the GLI study.
Conclusions: Our findings show that it is important to always interpret ventilatory function tests in any individual by
comparing it with reference values obtained from a well-defined population of healthy subjects of the same ethnic
origin in similar geographic location.
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Background
Over the time, pulmonary function tests have evolved
from tools for physiologic study to clinical tools
widely used in assessing the respiratory status. Spir-
ometry is an important pulmonary function test for
assessing ventilatory function of the lungs. The meas-
urement of ventilatory indices is very important in
the identification and management of respiratory dis-
eases. Pulmonary function tests have also become a
part of routine health examination in respiratory, oc-
cupational, and sports medicine. However, the results
of pulmonary function tests should be interpreted in
relation to reference values [1, 2].
Reference data are important for interpreting pul-
monary function test results and can aid in the man-
agement of respiratory diseases. Factors such as age,
sex, height, and race or ethnic origin have been
shown to be important determinants of pulmonary
function measurements [1–4]. Therefore, reference
equations incorporating these factors have been used
in North America [5, 6] and Europe [7–9] for several
decades with some as far back as the sixties and sev-
enties. These reference equations derived from sur-
veys conducted in these regions are of limited use in
Nigerians because of ethnic and regional differences
in pulmonary function [10]. Even the recently pub-
lished multi-ethnic global lung function 2012 equa-
tions are not useful in Nigerians because it did not
include participants from Nigeria [11].
Ideally, reference values should be derived from a
healthy and representative population tested by stan-
dardized technical methods and subjected to appro-
priate statistical analysis. Many of the older studies
on pulmonary function in Nigerians fail to meet these
criteria [12–16]. Almost all the studies are not repre-
sentative of the general population. In some, the stud-
ies were restricted to students and staff of schools
and hospitals [12, 13, 16]. None of the studies was
done in more than one city/location and none in-
volved participants from rural communities. The in-
creasing importance of pulmonary function testing in
diagnosing and managing lung diseases and assessing
improvement has necessitated the need for locally de-
rived reference equations from a sample of the gen-
eral Nigerian population.
In addition, most of the available studies on pulmon-
ary function tests in Nigeria were done several decades
ago. However, as measurement techniques, equipment,
and population characteristics evolve, there is a concur-
rent need to keep reference data up-to-date to reflect
these changes [9].
This work was therefore aimed at providing up-to-date
reference data for spirometric indices from a sample of
the general adult Nigerian population.
Methods
The survey was carried out in four (Asa, Ilorin East,
Irepodun and Offa) out of the sixteen local government
authority (LGA) in Kwara state from.
A cross sectional design aimed at obtaining represen-
tative sample of the population was used. Allowing for a
5% margin of error at 95% confidence interval and as-
suming that 60% of subjects will meet the 2005 ATS/
ERS criteria [17] (as reported by the PLATINO survey
[18]), the estimated sample size was about 640. However,
a sample size of 720 subjects was recruited.
The surveyed local government authorities were se-
lected by balloting. Participants were selected from the
LGA headquarters and the nearest towns/villages to
them. The selected sites were stratified according to the
polling units and consecutive households were selected.
All consenting individuals, in selected households, who
fulfilled the selection criteria, were recruited until the
sampling quota of each LGA was reached. The sampling
quota was calculated based on the estimated population
of the LGAs in the 2006 Census. Selected individuals
who were unable to perform the spiromtery satisfactorily
(see acceptability and repeatability criteria below) were
replaced by newly selected individuals.
Healthy individuals who had never smoked cigarette
were recruited if they were 18 years and above, able to
perform spirometry satisfactorily, had no history of
chronic illness such as sickle cell disease, without cardio
respiratory symptoms or history of previously diagnosed
cardio respiratory diseases and no history of abdominal
or thoracic surgery/injury, eye surgery or heart attack in
the last six months. They were without any evidence of
cardio respiratory abnormality on physical examination.
Weight in kilograms (kg) was measured to the nearest
0.1 kg with subjects in minimal clothing without shoes
on. Standing height in centimeter (cm) was measured to
the nearest 0.1 cm without shoes, with both feet flat on
the ground and apposed at the medial malleoli. The
heels, buttocks and occiput were placed against the ver-
tical bar, with the horizontally applied bar resting on the
subject’s head.
Data collection was carried out by trained assistants
under the supervision of the principal researcher (AEF).
Interviewer administered questionnaire modeled on the
American Thoracic society’s questionnaire was used.
The initial part of the questionnaire contained questions
on sociodemographic characteristics and evaluation to
determine whether the subject was eligible for spirom-
etry. The assistants were trained for two days and were
required to perform at least 10 satisfactory spirometry
before being selected for the survey. Spirometry was per-
formed using Spiro lab III by MIR England. The spirom-
eter has an auto sensor turbine for body temperature,
pressure and water vapour saturated (BTPS) changes
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and so automatically correct spirometric reading for the
body temperature and atmospheric pressure. The equip-
ment was calibrated daily with a 3 l syringe. Measure-
ments of spirometric indices were made in the upright
(straight-backed) sitting position without a nose clip
obstructing the nostrils. The subject to be tested was
first made to be thoroughly familiar with the machine
and the technique of the test. For FVC maneuver, the
procedure was explained and demonstrated to the indi-
vidual. The subject was told to sit straight with head
slightly elevated, then inhaled maximally and rapidly,
place the mouthpiece in the mouth and close the lips
tightly around it, exhale maximally until no more air can
be expelled while still maintaining an upright posture.
The procedure was closely monitored to ensure it was
acceptable. Thereafter the spirogram was examined for
acceptability and repeatability criteria according to the
ATS/ERS criteria [17]. A spirogram is acceptable if there
is a satisfactory start of expiration (no hesitation), no air
leak, no coughing during the procedure, no cessation of
flow during the procedure and no evidence of extra
breathing taken during the procedure. Measurement
with an unacceptable start of test or an unusable curve
was discarded before applying the repeatability criteria.
The acceptable spirogram was also examined for repeat-
ability criteria (the largest 2 values of FVC within
150mls of each other and the 2 largest values of FEV1
within 150mls of each other). If an individual achieved 3
acceptable readings that met the repeatability criteria,
the session is concluded for the individual. If both cri-
teria were not met, the testing was continued until the
criteria were met or the individual was excluded from
the survey after a total of 8 unacceptable tests have been
performed. For VC procedure, the procedure was ex-
plained and demonstrated to the subject. The individual
was instructed to completely fill and empty the lungs
during the procedure which was performed in a relaxed
manner (not forced) except near the end-inspiration and
end-expiration. The subject was instructed to exhale
completely, then, inhale completely and finally exhale
completely through the mouthpiece. For the MVV
procedure, it was explained and demonstrated to the
subject. The individual was told to close the lips
tightly around the mouthpiece and 3 resting tidal
breaths were obtained, followed by breathing rapidly
and deeply as possible for 12 s. Result was acceptable
if it was performed with maximal effort without evi-
dence of leakage, hesitation and tidal volume during
the procedure was greater than the subjects resting
tidal volume.
The largest VC, FVC, FEV1, FEV1/FVC, FEV3, FEV6,
MMEF, PEFR, FIVC, FIV1, PIF and MVV were recorded
for each participant. All tests were performed between
9:00 am and 1:00 pm.
Data analysis
Data analysis was done using the Statistical Package for
Social Science software version 15.0. The data of height,
age and lung function parameters was expressed as
means ± SD for each sex separately. The distribution of
the independent contributing variables was then exam-
ined for skewness and kurtosis to determine whether
transformations will be necessary before performing re-
gression analysis. Various regression models including
quadratic, power functions, logtransformed and linear
relationships were compared. For all lung indices exam-
ined, simple linear models provided more acceptable fits
to the data. Therefore, linear models were chosen as the
basic format for evaluating the relationships between the
dependent variables and the independent variables.
Dependent variables (VC, FVC, FEV1, FEV1/FVC, FEV3,
FEV6, MMEF, PEFR, FIVC, FIV1, PIF and MVV) were
regressed against height and age in different sex categor-
ies. They were first regressed individually against height
and age. Stepwise multiple regression analyses were then
used to determine which combination of variables would
best fit the model. Predictor variables were retained in the
regression model only if they significantly improved the
explained variance of the dependent variable. The equa-
tions with the lowest residual standard deviations and
highest coefficients of determination (R2) were considered
acceptable, if each included variable contributed signifi-
cantly to the model (p < 0.05). Lower limits of normal
range were calculated as the lower fifth percentile of the
distribution of the residuals from each equation.
In addition, spirometry of the population studied ob-
tained by predicted equations of the present work and
those of previous studies and the measured spirometry
was compared using paired t test. A p value of < 0.05
was taken as significant.
Results
Seven hundred and twenty participants made up of 358
males and 362 females who satisfactorily completed the
spirometric measurements using the ATS/ERS [17] re-
producibility and acceptability criteria were included in
this analysis. Their age distribution is shown in Table 1.
Majority of the males are in the 26–35 year age group
Table 1 Age distribution (in years) of the participants
Age
group
Males (358) Females (362)
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whereas the majority of the females are in the 56–65
year age group.
Anthropometric characteristics and spirometric pa-
rameters of the male and female participants are sum-
marized in Table 2. The mean, median, skewness and
kurtosis of the parameters indicated that regression was
possible without need for data transformation. The
males are younger, taller and have higher values of spiro-
metric indices (except for FEV1/FVC) than the females.
The prediction equations derived for the various spiro-
metric parameters after multiple regression analysis are
described in Table 3. All the parameters correlated
negatively with age and positively with height. Figures 1
and 2 demonstrate the linear fall of the spirometric pa-
rameters with age.
A comparison of spirometric values derived by predic-
tion equations of the present study with mean measured
values and those of various other studies in Nigeria and
other parts of the world are presented in Table 4. It
shows that our values are higher than values obtained
from previous studies from Nigeria but the difference is,
however, not statistically significant. Likewise, there are
no statistically significant differences between values
from our equations and those from study done in
Ethiopia. Our FVC and FEV1 values are, however, signifi-
cantly lower than values from Iran. Values from Poland
Table 2 Anthropometric and spirometric parameters in male and female participants
Parameters Range Mean SD Median Skewness Kurtosis
Males(N = 358)
Age (years) 18–65 38.3 14.9 37.0 0.529 −1.038
Height (cm) 155.0–185.0 170.7 8.0 170.0 −0.140 −1.120
VC (Liters) 2.71–5.80 4.10 0.81 4.00 0.162 −0.733
FVC (Liters) 2.42–4.99 3.81 0.73 3.98 −0.297 −1.091
FEV1 (Liters) 2.10–4.39 3.37 0.67 3.46 −0.213 −1.092
FEV1/FVC (%) 77.6–95.2 88.4 4.7 89.4 −0.526 −0.621
FEV3 (Liters) 2.41–4.59 3.69 0.70 3.78 −0.296 −1.273
FEV6 (Liters) 2.42–4.98 3.81 0.73 3.98 −0.297 −1.091
MMEF (Liters/sec) 2.65–7.25 4.70 1.23 4.42 0.423 −0.676
PEFR (Liters/sec) 5.62–12.50 9.29 1.71 9.16 −0.191 −0.575
MVV (Liters/min) 73.5–212.4 137.7 31.9 139.9 −0.750 −0.281
FIVC (Liters) 2.11–4.86 3.56 0.68 3.48 −0.161 −0.645
FIV1 (Liters) 1.92–4.31 3.29 0.63 3.28 −0.206 −0.625
PIF (Liters/sec) 5.59–10.72 7.86 1.20 7.99 −0.492 −0.322
Females (N = 362)
Age (years) 18–63 42.5 15.4 42.0 - 0.148 −1.496
Height (cm) 143.0–172.0 156.8 6.1 158.0 −0.023 0.069
VC (Liters) 1.64–5.08 2.65 0.72 2.64 1.362 3.218
FVC (Liters) 1.73–3.25 2.52 0.47 2.67 −0.327 −1.275
FEV1 (Liters) 1.46–3.00 2.24 0.44 2.25 −0.179 −1.044
FEV ratio (%) 77.6–98.9 89.5 5.74 89.3 −0.152 −0.410
FEV3 (Liters) 1.64–3.25 2.45 0.46 2.56 −0.295 −1.171
FEV6 (Liters) 1.73–3.25 2.52 0.47 2.66 −0.328 −1.278
MMEF (Liters/sec) 1.96–6.30 3.66 1.10 3.56 0.579 −0.278
PEFR (Liters/sec) 3.56–8.33 5.91 1.24 5.90 0.183 −0.543
MVV (Liters/min) 57.6–120.0 89.6 15.2 93.1 −0.126 −0.878
FIVC (Liters) 1.55–3.01 2.39 0.49 2.62 −0.462 −1.303
FIV1 (Liters) 1.32–2.68 2.12 0.46 2.38 −0.454 −1.368
PIF (Liters/sec) 3.05–7.15 5.19 0.94 5.30 −0.315 −0.124
SD standard deviation, VC vital capacity, FVC forced vital capacity, FEV1 forced expiratory volume in one second, FEV ratio FEV1/FVC%, FEV3 forced expiratory
volume in three seconds, FEV6 forced expiratory volume in six seconds, PEFR peak expiratory flow rate, MMEF maximal mid expiratory flow, MVV maximal
voluntary ventilation, FIVC forced inspiratory vital capacity, FIV1 forced inspiratory volume in one second, PIF peak inspiratory flow
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are also significantly higher than our values. We also
compared values from our equations with the values de-
rived for Afro Americans in the landmark global lung
function initiative study. Our maximal mid expiratory
flow values were significantly higher in both males and
females and in addition our female FVC values were
lower than the values for the Afro Americans. Our
FEV1/FVC was higher than the values for the Afro
Americans although the difference was not statistically
significant.
Table 3 Derived equations for various spirometric parameters
of male and female subjects
Males
VC (R2 = 0.745, RSD = 0.41225)
Predicted ˗1.163 + (-0.035)A + 0.039H
LLN ˗2.148 + (-0.037)A + 0.034H
FVC (R2 = 0.837, RSD = 0.29524)
Predicted ˗ 0.848 + (-0.034)A + 0.035H
LLN ˗1.487 + (-0.035)A + 0.031H
FEV1 (R
2 = 0.821, RSD = 0.28328)
Predicted ˗0.834 + (-0.031)A + 0.031H
LLN ˗1.448 + (-0.032)A + 0.028H
FEV ratio (R2 = 0.08, RSD = 4.6897)
Predicted 82.448 + (-0.120)A + 0.038H
LLN 72.288 + (-0.206)A + (0.029)H
FEV3 (R
2 = 0.845, RSD = 0.27565)
Predicted ˗0.613 + (-0.033)A + 0.033H
LLN ˗1.210 + (-0.034)A + 0.029H
FEV6 Same as for FVC
MMEF (R2 = 0.450, RSD = 0.91509)
Predicted 3.830 + (-0.051)A + 0.017H
LLN 1.997 + (-0.054)A + 0.015H
PEFR (R2 = 0.573, RSD = 1.11787)
Predicted ˗4.199 + (-0.054)A + 0.091H
LLN ˗6.621 + (-0.061)A + 0.078H
MVV (R2 = 0.594, RSD = 20.3577)
Predicted 34.221 + (-1.378)A + 0.915H
LLN 20.883 + (-1.408)A + 0.671H
FIVC (R2 = 0.707, RSD = 0.37060)
Predicted ˗1.407 + (-0.027)A + 0.035H
LLN ˗2.210 + (-0.029)A + 0.031H
FIV1 (R
2 = 0.661, RSD = 0.36884)
Predicted ˗1.572 + (-0.023)A + 0.034H
LLN ˗2.371 + (-0.025)A + 0.029H
PIF (R2 = 0.458, RSD = 0.88486)
Predicted ˗2.366 + (-0.029)A + 0.066H
LLN ˗4.283 + (-0.035)A + 0.056H
Females
VC (R2 = 0.688, RSD = 0.40299)
Predicted ˗2.980 + (-0.029)A + 0.044H
LLN ˗3.975 + (-0.032)A + 0.038H
FVC (R2 = 0.876, RSD = 0.16623)
Predicted ˗1.578 + (-0.022)A + 0.032H
LLN ˗1.988 + (-0.023)A + 0.030H
FEV1 (R
2 = 0.761, RSD = 0.21655)
Predicted ˗1.861 + (-0.018)A + 0.031H
Table 3 Derived equations for various spirometric parameters
of male and female subjects (Continued)
LLN ˗2.195 + (-0.019)A + 0.028H
FEV ratio (R2 = 0.034, RSD = 5.6592)
Predicted 60.815 + (-0.044A) + 0.177H
LLN 48.554 + (-0.054A) + 0.152H
FEV3 (R
2 = 0.860, RSD = 0.17413)
Predicted ˗2.374 + (-0.020)A + 0.036H
LLN ˗2.804 + (-0.021)A + 0.033H
FEV6 (R
2 = 0.876, RSD = 0.16555)
Predicted ˗1.521 + (-0.022)A + 0.032H
LLN ˗1.930 + (-0.023)A + 0.029H
MMEF (R2 = 0.552, RSD = 0.73682)
Predicted ˗3.830 + (-0.041)A + 0.059H
LLN ˗5.548 + (-0.045)A + 0.059H
PEFR (R2 = 0.611, RSD = 0.77743)
Predicted ˗4.986 + (-0.045)A + 0.082H
LLN ˗5.903 + (-0.049)A + 0.070H
MVV (R2 = 0.550, RSD = 10.2106)
Predicted 3.752 + (-0.578)A + 0.752H
LLN 5.102 + (-0.939)A + 0.579H
FIVC (R2 = 0.676, RSD = 0.27872)
Predicted ˗1.201 + (-0.020)A + 0.028H
LLN ˗1.888 + (-0.022)A + 0.024H
FIV1 (R
2 = 0.575, RSD = 0.30378)
Predicted ˗0.762 + (-0.018)A + 0.023H
LLN ˗1.511 + (-0.020)A + 0.019H
PIF (R2 = 0.564, RSD = 0.62244)
Predicted ˗3.928 + (-0.030)A + 0.066H
LLN ˗5.464 + (-0.034)A + 0.057H
R2 coefficient of determination, RSD residual standard deviation, LLN lower
limit of normal, A age in years, H height in centimetres, VC vital capacity
(Liters), FVC forced vital capacity (Liters), FEV1 forced expiratory volume in one
second (Liters), FEV ratio FEV1/FVC%, FEV3 forced expiratory volume in three
seconds (Liters), FEV6 forced expiratory volume in six seconds (Liters), PEFR
peak expiratory flow rate(Liters/sec), MMEF maximal mid expiratory flow
(Liters/sec), MVV maximal voluntary ventilation (Liters/min), FIVC forced
inspiratory vital capacity (Liters), FIV1 forced inspiratory volume in one second
(Liters), PIF peak inspiratory flow (Liters/sec)
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Discussion
Measurements of ventilatory function are not only im-
portant as a diagnostic tool; they are also useful in fol-
lowing the natural history of disease over a period of
time, assessing the preoperative risk and in quantifying
the effects of treatment. Spirometry is very important in
the field of respiratory care because it is able to identify
obstructive pathology about 5–15years prior to the other
techniques [19].
Ethnicity has been recognized as one of the major fac-
tors responsible for variability of lung function [2–4, 20,
21]. It is therefore important to establish reference
values relevant to the ethnic characteristics of local
population. Changes in population dynamics also neces-
sitate the need for periodic review of such established
reference values [22].
We used linear regression models to obtain equations
for reference values of spirometric indices for adult
Fig. 1 a-f Predicted mean and lower limit of normal (LLN) for FVC, FEV1, FEV ratio, PEFR, MMEF and MVV in males (height 170 cm) by age. FVC =
forced vital capacity (Liters), FEV1 = forced expiratory volume in one second (Liters), FEV ratio = FEV1/FVC%, PEFR = peak expiratory flow rate(Liters/
s), MMEF =maximal mid expiratory flow (Liters/s), MVV =maximal voluntary ventilation (Liters/min)
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Nigerians from a sample of the general population aged
18–65 years (males) and 18–63 years (females). As
found in many other studies [3, 6, 12, 15, 23], the
current study found that the most important predict-
ive variables were height and age and linear equations
performed satisfactorily.
Our study shows that the values of the spirometic in-
dices increase with increasing stature but decrease with
increasing age in both sexes as reported in previous
studies [15, 23]. The sex difference in all the indices is
also apparent as all the indices, except FEV1/FVC, are
higher in men than in women. This trend had been
Fig. 2 a-f Predicted mean and lower limit of normal (LLN) for FVC, FEV1, FEV ratio, PEFR, MMEF and MVV in females (height 165 cm) by age.
FVC = forced vital capacity (Liters), FEV1 = forced expiratory volume in one second (Liters), FEV ratio = FEV1/FVC%, PEFR = peak expiratory flow
rate(Liters/s), MMEF =maximal mid expiratory flow (Liters/s), MVV =maximal voluntary ventilation (Liters/min)
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reported earlier. The reason for this is not an objective
of this study but previous studies have suggested differ-
ences in muscular strength, size and shape of the thor-
acic cage and elasticity of the lung as possible reasons
for the observed sex difference in values of spirometric
indices [23–25].
When comparison was made using a standard age and
height as shown in Table 4, our results show that our
values are higher than values obtained from previous
studies in Nigeria (except FEV1/FVC) but the differences
were not statistically significant [16]. This suggests that
although the values are increasing, the increase is yet to
be significantly different from values obtained using the
past equations. The implication of this is that there is
need for periodic study to derive new equations so as to
recognize when there is significant difference.
We also compared values of PEFR derived from our
linear equations with the curvilinear equations from
Table 4 Comparison between spirometric values obtained by predicted equations of the present study with mean measured values
and those of previous studies
Parameters Age range (years) Subjects (No) FVC (Litres) FEV1 (Litres) Ratio (%) MMEF (Litres/second) PEFR (Litres/second)
Male (age = 38.5 years and height = 170.7)
Predicted present study 18–65 358 3.82 3.27 84.3 4.78 9.27
Mean present study 18–65 358 3.81 3.37 88.4 4.70 9.29
SD p = 0.97 p = 0.69 p = 0.53 p = 0.82 p = 0.98
Elebute et al [14] 17–54 142 – – – – 8.08
SD – – – – p = 0.18
Njoku et al [15] 15–60 668 - - - - 8.84
SD - - - - p = 0.47
Erhabor et al [16] 19–60 241 3.59 3.00 84.6 – 8.71
SD p = 0.46 p = 0.31 p = 0.97 – p = 0.30
Mengesha et al [23] 18–47 143 4.48 3.62 – – 8.48
SD p = 0.10 p = 0.29 – – p = 0.63
Golshan et al. [24] 21–82 1302 4.59 3.97 86.5 5.12 10.20
SD p = 0.004* p = 0.002* p = 0.67 p = 0.23 p = 0.12
Ostrowski et al. [26] 40–80 49 5.50 4.45 – – –
SD p = 0.007* p = 0.02* – – –
GLI Afro American [11] 3–95 1520 4.05 3.33 82.0 3.40
SD p = 0.33 p = 0.76 p = 0.63 p < 0.01*
Female (age = 42.5 and height = 156.8)
Predicted present study 18–65 362 2.51 2.23 86.7 3.68 5.96
Mean present study 18–65 362 2.52 2.24 89.5 3.66 5.91
SD p = 0.96 p = 0.95 p = 0.67 p = 0.94 p = 0.91
Elebute et al [14] 17–44 88 – – – – 5.60
SD – – – – p = 0.61
Njoku et al [15] 15–60 341 - - - - 5.99
SD - - - - p = 0.95
Mengesha et al [23] 18–47 117 2.94 2.30 – – –
SD p = 0.12 p = 0.77 – – –
Golshan et al [24] 21–80 1110 3.14 2.74 87.6 3.64 6.77
SD p < 0.001* p < 0.01* p = 0.87 p = 0.86 p = 0.04*
Ostrowski et al [26] 40–80 87 3.45 2.93 – – –
SD p = 0.004* p = 0.01* – – –
GLI Afro American [11] 3–95 2025 2.87 2.36 83.0 2.58
SD p = 0.03* p = 0.33 p = 0.44 p < 0.01*
FVC forced vital capacity, FEV1 forced expiratory volume in one second, ratio FEV1/FVC%, PEFR peak expiratory flow rate, MMEF maximal mid expiratory flow, GLI
global lung finction initiative study, SD statistical significance, * = statistically significant difference
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Njoku et al. [15] and found out that although our values
are higher, the difference was not statistically significant
even at both ends of the age distribution. This shows
that our linear equations performed satisfactorily for the
age range of the population studied. Similarly, there was
no significant difference between values from our equa-
tions and those obtained from study among Ethiopians
[23]. This is in agreement with the previous studies on
spirometric parameters in Nigeria and other populations
of African descent [14–16]. Compared to report from
Iran, our FVC and FEV1values (in males and females) as
well as PEFR (in females) are significantly lower [24].
Our values are also lower than values from Poland [26].
The differences obtained in these indices among the eth-
nic groups may be attributable to complex interrelation-
ship of factors such as genetic and physical make up of
the people in the ethnic groups, altitude, environmental
differences, physical activities, and tobacco smoking [2–
4, 20–22, 27]. This is why it is important to always inter-
pret ventilatory function tests in any individual by com-
paring it with reference values obtained from a well-
defined population of healthy subjects of the same eth-
nic origin. Similar to an earlier report from Tunisia [28],
we observed disparities between values obtained from
our equations and those for Afro Americans using the
GLI equations [11]. These disparities may be due to
many reasons including substantial differences in an-
thropometric, socioeconomic and environmental factors.
It suggests that the use of the multi-ethnic GLI equa-
tions for Nigerians may lead to misinterpretation of spir-
ometry data especially among the females and this may
result in inappropriate diagnosis and/or management.
This is in agreement with a Swedish study, by Backman
et al. [29], which reported that the use of GLI reference
values may produce biased prevalence estimates of lung
diseases in Sweden, especially among women.
One of the limitations of our study is that the partici-
pants are from kwara state only and so it may not repre-
sent the true picture of the whole country. However, the
fact that the participants were selected from the general
population is an important improvement over previous
studies which selected participants from non representa-
tive groups such as students, health workers, males’ only
etc. [12–16]. Another drawback of our study is that it in-
cluded participants with age range 18-65years unlike the
current trend of trying to include people of all ages in
spirometric reference equations [11]. In spite of the re-
cent endorsement and calls for the adoption of the GLI
reference values in clinical practice worldwide [30, 31],
our study is still very relevant in Nigeria context because
the GLI study did not include data from Nigeria and in
addition spirometry is being done in few centers in
Nigeria almost entirely in adults only. Our spirometric
data were collected without the use of nose clips in the
subjects because majority of them objected to its use.
This is likely to have affected our results especially the
inspiratory parameters.
Our prediction equations for spirometry indices fill a
serious lacuna in an important aspect of pulmonary care
in Nigeria for many important reasons. First of all, it is
the first study to describe the derivation of spiromteric
reference values for Nigerians from a sample of the gen-
eral population unlike previous studies which selected
participants from non representative groups. Another
point in favour of our study is its size and representa-
tiveness, including a substantial proportion of people in
older age groups, who were underrepresented in previ-
ous studies. The sample size is fairly well distributed
over the age group in this study because we went to the
communities to select our participants and this may
have positive influence on the accuracy of our equations.
However, caution is required in interpreting the predic-
tion equations for the elderly because of possible bias as
a result of error in age. Many elderly individuals in
Nigeria do not have proper records of their date of birth
and usually estimate it by events which occurred around
the time of their birth.
Also our study has provided prediction equations for
spirometric indices such as VC, FEV1/FVC, FEV3, FEV6,
MMEF, FICV, FIV1 and PIF which were not included in
previous studies from Nigeria. Some of the indices are
now being considered as important variables to use in
some special situations. For example, in obstructive lung
disease, the FVC may be less than the slow VC because
of earlier closure during the forced manoeuvre. This
may lead to an overestimation of the FEV1/FVC. Thus
the FEV1/VC may be a more sensitive index of airflow
obstruction [19]. Furthermore, FEV1/FEV6 and FEV6
have been suggested as alternative to FEV1/FVC and
FVC in the spirometric detection of airway obstruction
and restriction [32].
Another strength of our study is that it is the first
study, in Nigerians, to provide prediction equations for
the lower limit of normal (LLN) for spirometric parame-
ters. The LLN derived directly from the population pro-
vides more accurate estimates than assuming a constant
value of less than 80% of the predicted as being low. For
example, Hardie et al. [33] have shown that the use of a
fixed FEV1/FVC cut-off point of 70% for defining
chronic obstructive pulmonary disease (COPD), as rec-
ommended by the Global Initiative for COPD, may lead
to significant degree of overdiagnosis of both the pres-
ence and severity of COPD in the elderly population. In
agreement with that study, our present prediction equa-
tions indicate that a lower FEV1/FVC should be used in
the elderly. Based on our prediction equations, a 65 year
old male with a height of 170 cm has a LLN for FEV1/
FVC of 63.9% and this is expected to be even lower for
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shorter individuals. The dependency of LLN of spiromet-
ric parameters on age does not only affect the FEV1/
FVC. As shown in Figs. 1 and 2, the LLN of all the indi-
ces is dependent on age. Although both ATS and the
ERS accept the use of the 5th percentile to define the
LLN (which unlike the percentage of the predicted, is
free from bias due to age, height, sex or ethnic group),
some authors have observed that a substantial percent-
age of subjects (±10.4%) have values lower than the 5th
percentile [1, 9, 34].
Interaction with colleagues in centres with pulmonary
laboratories in Nigeria reveal that most of them rely on
the default settings for predicted values for different
ranges offered by the manufacturer and it seems as if
many of them are still unaware of the problems associ-
ated with such practices, especially the use of fixed per-
centage as LLN. We advocate for the use of our new
prediction equations in order to help in surmounting
this great barrier to proper care of our patients with re-
spiratory disorders.
Conclusion
We present the findings from our study, the first of such
to select representative sample from the general adult
population, the first to provide equations for some pa-
rameters which were not included in previous equations
and also the first to provide equations for the LLN in
Nigerians. Our new prediction equations for spirometric
indices are a significant improvement over the previous
Nigerian equations. The use of our prediction equations
is expected to ensure that the prevalence estimates of
adult with spirometric parameters below the LLN are
possible using the LLN equations derived from the gen-
eral Nigerian population rather than assuming a value
below 80% as is currently done. Our study also has
unequivocal clinical implications because everyday
decisions are made with regard to diagnosis, treatment
and prevention of respiratory conditions on the basis of
spirometric results in relation to reference values.
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